Susquehanna International Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-614,700
| Closed | -$7.65M | – | 10820 |
|
|
2016
Q4 | $7.65M | Buy |
614,700
+99,000
| +19% | +$1.19M | ﹤0.01% | 1837 |
|
|
2016
Q3 | $7.06M | Buy |
515,700
+296,300
| +135% | +$2.98M | ﹤0.01% | 1848 |
|
|
2016
Q2 | $1.62M | Buy |
219,400
+600
| +0.3% | +$4.5K | ﹤0.01% | 3944 |
|
|
2016
Q1 | $1.4M | Sell |
218,800
-95,200
| -30% | -$534K | ﹤0.01% | 4432 |
|
|
2015
Q4 | $1.96M | Sell |
314,000
-220,900
| -41% | -$1.45M | ﹤0.01% | 4069 |
|
|
2015
Q3 | $3.12M | Sell |
534,900
-92,900
| -15% | -$716K | ﹤0.01% | 3430 |
|
|
2015
Q2 | $5.19M | Sell |
627,800
-186,500
| -23% | -$1.65M | ﹤0.01% | 2862 |
|
|
2015
Q1 | $6.71M | Sell |
814,300
-461,400
| -36% | -$3.41M | ﹤0.01% | 2335 |
|
|
2014
Q4 | $8.76M | Sell |
1,275,700
-172,100
| -12% | -$1.08M | ﹤0.01% | 2180 |
|
|
2014
Q3 | $7.82M | Sell |
1,447,800
-279,400
| -16% | -$1.63M | ﹤0.01% | 2409 |
|
|
2014
Q2 | $11M | Buy |
1,727,200
+175,900
| +11% | +$1.21M | ﹤0.01% | 2013 |
|
|
2014
Q1 | $12.5M | Sell |
1,551,300
-1,757,000
| -53% | -$13.7M | 0.01% | 1746 |
|
|
2013
Q4 | $22.6M | Buy |
3,308,300
+2,478,400
| +299% | +$13.4M | 0.01% | 1236 |
|
|
2013
Q3 | $15.3M | Buy |
829,900
+595,300
| +254% | +$11.6M | 0.01% | 1445 |
|
|
2013
Q2 | $4.1M | Buy |
+234,600
| New | +$4.16M | ﹤0.01% | 2876 |
|
Other funds holding ARIA
Susquehanna International Group's ARIA Position: Q1 2017 in Review
Susquehanna International Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 11,138 shares — an estimated $139K sold.
Susquehanna International Group first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $18.7M in Q4 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Susquehanna International Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Susquehanna International Group sold 11,138 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $139K.
- Susquehanna International Group first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
- Susquehanna International Group's Ariad Pharmaceuticals Inc position peaked at $18.7M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.